Stock data
Krystal Biotech, Inc. (KRYS)
Krystal Biotech, Inc. (KRYS) reported revenue of US$389.13M and net income of US$204.83M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$389.13M | — | US$161.29M | US$204.83M | — |
| 2024 | US$290.51M | — | US$65.75M | US$89.16M | — |
| 2023 | US$50.70M | — | -US$109.62M | US$10.93M | — |
| 2022 | US$0.00M | — | -US$145.20M | -US$139.97M | — |
| 2021 | US$0.00M | — | -US$68.28M | -US$69.57M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$119.22M | US$54.77M | — |
| 2026-03-31 | US$116.36M | US$55.93M | — |
| 2025-12-31 | US$107.11M | US$51.40M | — |
| 2025-09-30 | US$97.80M | US$79.36M | — |
| 2025-06-30 | US$96.04M | US$38.33M | — |
| 2025-03-31 | US$88.18M | US$35.73M | — |
| 2024-12-31 | US$91.14M | US$45.48M | — |
| 2024-09-30 | US$83.84M | US$27.18M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.